These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4392344)

  • 1. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation.
    Laddu R
    Eur J Pharmacol; 1970 Feb; 9(2):129-35. PubMed ID: 4392344
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):61-71. PubMed ID: 4151909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
    Somani P
    Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.
    Laddu AR; Somani P
    J Pharmacol Exp Ther; 1969 Nov; 170(1):79-83. PubMed ID: 4390815
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-activity relationship for antiarrhytmic actions of -receptor blocking drugs.
    Somani P; Laddu AR
    Eur J Pharmacol; 1971 May; 14(3):209-16. PubMed ID: 4405540
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between heart rate and ouabain toxicity in the dog heart-lung preparation.
    Lahiri PK; Laddu AR
    Jpn Heart J; 1973 Jul; 14(4):357-65. PubMed ID: 4542950
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999).
    Somani P; Watson DL
    J Pharmacol Exp Ther; 1968 Dec; 164(2):317-25. PubMed ID: 5699093
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
    Cheymol G; Honnorat C; Schmitt H
    Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Optical antipodes of adrenergic beta receptor blocking agent 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol].
    Meier M; Hedwall PR; Imhof P; Wilhelm M; Brunner H
    Arzneimittelforschung; 1970 Dec; 20(12):1890-6. PubMed ID: 4395650
    [No Abstract]   [Full Text] [Related]  

  • 11. Propranolol (Inderal) in experimentally-induced cardiac arrhythmias.
    Lucchesi BR; Whitsitt LS; Brown NL
    Can J Physiol Pharmacol; 1966 Jul; 44(4):543-7. PubMed ID: 5966564
    [No Abstract]   [Full Text] [Related]  

  • 12. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic potency of N-propyl ajmaline with untoward response of ventricular fibrillation in excess dose.
    Nakayama K; Koike H; Oshima T; Hashimoto K
    Jpn J Pharmacol; 1973 Feb; 23(1):9-16. PubMed ID: 4146270
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic actions of BC 105.
    Ahmad M; Achari G
    Jpn J Pharmacol; 1969 Mar; 19(1):19-24. PubMed ID: 5306219
    [No Abstract]   [Full Text] [Related]  

  • 15. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124].
    Fujita T; Miyazaki M
    Masui; 1972 May; 21(5):450-7. PubMed ID: 4403862
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compounds related to 4-disopropylamino-2-phenyl-2(2-pyridyl)butyramide. Their synthesis and antiarrhythmic activity.
    Yen CH; Lowrie HS; Dean RR
    J Med Chem; 1974 Nov; 17(11):1131-5. PubMed ID: 4412561
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular fibrillation and catecholamine responses during profound hypothermia in dogs.
    Warner WA; Anton AH; Andersen TW; Swofford LJ
    Anesthesiology; 1970 Jul; 33(1):43-51. PubMed ID: 4393416
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
    Marmo E; Saini RK; Caputi AP
    Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.